1. Home
  2. KVHI vs CNTB Comparison

KVHI vs CNTB Comparison

Compare KVHI & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KVH Industries Inc.

KVHI

KVH Industries Inc.

HOLD

Current Price

$7.33

Market Cap

118.4M

Sector

Technology

ML Signal

HOLD

Logo Connect Biopharma Holdings Limited

CNTB

Connect Biopharma Holdings Limited

HOLD

Current Price

$2.22

Market Cap

128.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KVHI
CNTB
Founded
1978
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
118.4M
128.6M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
KVHI
CNTB
Price
$7.33
$2.22
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$8.50
AVG Volume (30 Days)
68.1K
105.3K
Earning Date
03-05-2026
02-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$107,407,000.00
$762,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$14.15
$24,739.01
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.69
$0.51
52 Week High
$7.69
$3.28

Technical Indicators

Market Signals
Indicator
KVHI
CNTB
Relative Strength Index (RSI) 62.14 44.13
Support Level $7.10 $2.02
Resistance Level $7.69 $2.83
Average True Range (ATR) 0.36 0.18
MACD -0.00 -0.05
Stochastic Oscillator 70.18 23.38

Price Performance

Historical Comparison
KVHI
CNTB

About KVHI KVH Industries Inc.

KVH Industries Inc provides integrated, end-to-end services, software, and hardware that support its customers' need for access to the Internet, VoIP, operations content, and entertainment services. It offers high-speed Internet and Voice over Internet Protocol (VoIP) services via satellite and integrated 5G/LTE cellular communications to mobile users at sea and on land. The company also provides commercially licensed entertainment, including news, sports, music, and movies, to commercial and leisure customers in the maritime, hotel, and retail markets. It operates in several geographic areas, including internationally. Revenues are generated from international locations, mainly consisting of Singapore, Canada, South America, European Union and other European countries, and other regions.

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

Share on Social Networks: